# Biocryst Pharmaceuticals Inc: Form 8-K, filed Jun 29, 2026

- Company: [Biocryst Pharmaceuticals Inc](/companies/bcrx.md) (CIK 882796)
- Form: 8-K
- Filed: 2026-06-29
- Accepted by EDGAR: Jun 29, 2026, 07:06 ET
- Period: 2026-06-25
- Accession: 0001171843-26-004333
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/882796/000117184326004333/f8k_062926.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/882796/000117184326004333/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/882796/000117184326004333/f8k_062926.htm

Filed Jun 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-004333. Last ingested by Listed: Nov 10, 2026, 16:39 ET. No prices; not investment advice.
